P1.14-55 Cost-Effectiveness of Ceritinib and Alectinib Vs Crizotinib in First-Line Anaplastic Lymphoma Kinase-Positive Advanced NSCLC
JOURNAL OF THORACIC ONCOLOGY（2019）
关键词
cost-effectiveness,Ceritinib plus Alectinib vs Crizotinib,advanced NSCLC
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要